Old Web
English
Sign In
Acemap
>
authorDetail
>
J. R. Brahmer
J. R. Brahmer
Bevacizumab
Carboplatin
Paclitaxel
Oncology
Medicine
2
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Genetic variants in angiogenesis pathway associated with clinical outcome in NSCLC patients (pts) treated with bevacizumab in combination with carboplatin and paclitaxel: Subset pharmacogenetic analysis of ECOG 4599
2009
W. Zhang
Suzanne E. Dahlberg
D. Yang
Alan Sandler
J. R. Brahmer
Joan H. Schiller
David P. Carbone
David H. Johnson
H Lenz
Show All
Source
Cite
Save
Citations (33)
Outcomes for elderly advanced stage non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (B) in combination with carboplatin (C) and paclitaxel (P): Analysis of Eastern Cooperative Oncology Group (ECOG) 4599 study
2007
Journal of Clinical Oncology
S. S. Ramalingam
Suzanne E. Dahlberg
Corey J. Langer
Robert Gray
Chandra P. Belani
J. R. Brahmer
Alan Sandler
Joan H. Schiller
David H. Johnson
Show All
Source
Cite
Save
Citations (20)
1